Restricted access to genome-editing technologies poses serious challenges for countries like India that urgently need such ...

Researchers have developed a new way to decipher the language of the brain by listening to and recording the fastest and faintest communications signals of neurons. This allows scientists to watch ...

In vivo CAR T-cell therapy could revolutionize cancer treatment by bypassing traditional manufacturing, reducing costs, and minimizing adverse events. Kelonia Therapeutics' KLN-1010 has shown ...

Vivo has already started taking pre-orders for the Vivo S50 series Vivo S50 is teased to feature a 50-megapixel camera Vivo S50 Pro Mini will pack LPDDR5X RAM ...

SHANGHAI, Dec. 6, 2025 /PRNewswire/ -- Vivacta Bio, a spin-off company of Grit Biotherapeutics advancing in vivo CAR-T therapies for oncology and autoimmune diseases, today announced encouraging ...

Vivo X300 price may start at Rs. 75,999 for the 12GB+256GB model The Pro variant reportedly matches the Oppo Find X9 Pro's pricing Vivo may price its Telephoto Extender Kit in India at Rs. 20,999 ...

Is the data publicly available? How good is the quality of the data? How difficult is it to access the data? Even if the first two answers are a clear yes, we still can’t celebrate, because the last ...

This valuable study expands the inventory of polyadenylated RNAs cleaved by the double-stranded RNA endonuclease Rnt1 in budding yeast, using solid methodology based on high-throughput sequencing.

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...